Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
Delayed Quote. Delayed Nyse - 02/25 04:03:37 pm
89.18 USD   -4.25%
02/25ABBVIE : Form 8.3 -
DJ
02/24ABBVIE : Form 8.3 -
DJ
02/24ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Update : Form 8.3 -AbbVie Inc -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
01/14/2020 | 10:45am EST
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                69,024,360  4.66724% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  69,024,360  4.66724% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                               438                    89.68 
--------------  -----------------------------  ----------------------- 
   Purchase                                48                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,400                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               700                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               600                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                                70                    89.63 
--------------  -----------------------------  ----------------------- 
   Purchase                               714                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                            15,864                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               618                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               200                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                               510                    89.06 
--------------  -----------------------------  ----------------------- 
   Purchase                            10,913                    90.05 
--------------  -----------------------------  ----------------------- 
     Sale                                 600                    89.68 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                               1,400                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                               8,900                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                                 700                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                              97,010                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                              19,830                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                              45,837                    89.06 
--------------  -----------------------------  ----------------------- 
     Sale                               4,308                    89.06 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                      NO 
-------------------------------------------------------  ------------------- 
Date of disclosure                                       13(th) January 2020 
-------------------------------------------------------  ------------------- 
Contact name                                                Lionel Colaco 
-------------------------------------------------------  ------------------- 
Telephone number                                                020 33956098 
-------------------------------------------------------  ------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ------------------- 
 
 
 
 
 
 

This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ABBVIE INC.
02/25ABBVIE : Form 8.3 -
DJ
02/24ABBVIE : Form 8.3 -
DJ
02/24ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/24ABBVIE : Announces Extension of Expiration Date for Exchange Offers for Allergan..
PR
02/21ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/21ABBVIE : Form 8.3 -
DJ
02/20ABBVIE : Declares Quarterly Dividend
PR
02/20ABBVIE : Form 8.3 - Abbvie Inc.
DJ
02/19ABBVIE : Form 8.3 - Abbvie Inc
DJ
02/19ABBVIE : to Present at the Cowen 40th Annual Health Care Conference
PR
More news